FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

2831011000001104: Seretide 250 Evohaler (GlaxoSmithKline) 120 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26319101000001114 Seretide 250 Evohaler (GlaxoSmithKline) 120 dose (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58202501000001119 Seretide 250 Evohaler (GlaxoSmithKline UK Ltd) 120 dose en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Is a Fluticasone 250micrograms/actuation / Salmeterol 25micrograms/actuation inhaler CFC free 120 dose true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Is pack of Seretide 250 Evohaler (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has NHS dm+d (dictionary of medicines and devices) freeness indicator CFC free true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has active ingredient Corticosterone false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has active ingredient Salmeterol xinafoate false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has active ingredient Salmeterol false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has active ingredient Fluticasone propionate false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has active ingredient Adrenal hormone agent false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has manufactured dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has AMP Seretide 250 Evohaler (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has dispensed dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start